Woodline Partners LP - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,457,000
-86.4%
139,907
-92.5%
0.04%
-88.2%
Q2 2021$18,101,000
+62.8%
1,866,073
+80.3%
0.34%
+36.8%
Q1 2021$11,116,000
-0.8%
1,034,991
+35.9%
0.25%
-16.8%
Q4 2020$11,201,000
-5.1%
761,465
-8.3%
0.30%
-23.3%
Q3 2020$11,801,000
+132.7%
830,497
+32.5%
0.39%
+92.5%
Q2 2020$5,071,000
+91.7%
626,810
-4.3%
0.20%
+6.3%
Q1 2020$2,645,000654,7810.19%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders